| DOSAGE FORM | TABLETS |
| PACK SIZE | 2 X 10 |
| STATUS | DRAP APPROVED (DRAP ENLISTMENT NO. 3531020410) |
| CATEGORY | ORTHOPEDIC, RHEUMATOLOGY |
COMPOSITION
- Celadrin ………… 350 mg
- Boswellia Extract ……….. 100 mg
- MSM ………. 150 mg
USES & INDICATIIONS
- An advance support for Joint Health
- Reduces pain due to OA and RA
- Reduces inflammation and relieve jojnt pain in the back, wrist, hip, knee & ankle and OA
- Provide flexibility to cartilage
- Helps to reduce joint pain and stiffness
- Promotes joint mobility and flexibility
- Reduces joint pain, stiffness and inflammation
SCIENTIFIC EVIDENCE
CELADRIN (CETYLATED FATTY ACIDS)
Cetylated fatty acids have been shown to reduce pain and increase functional performance in OA sufferers. The functional performance tested included: strength, range of motion, ability to climb stairs, and the ability to walk immediately after standing
MSM
Significant improvements were also observed in swelling [55] and stiffness [53]. MSM appears to be well-tolerated and safe as reported by the Food and Drug Administration (FDA)
Boswellia serrata
Boswellia serrata is well known to be rich in anti-inflammatory boswellic acids (3- O-acetyl-11-keto-beta-boswellic acid (AKBA), as the major potential active ingredient), which were shown to decrease pain (VAS, WOMAC pain), increase knee/hip flexion and walking distance (function and stiffness), as well as affecting the frequency of swelling if administered in patients with OA
